MYC

There are 332 papers on MYC in aging research: 6 trials and 30 observational studies in people, 151 in animals, 93 in cells, 38 reviews. The newest story, Nov 12, 2026: “Human cell types recovered differently after partial reprogramming”.

Gene

332 papers study it101 findings

HGNCNCBI GeneTaxon

10 new papers in 30 daysSee all 332 papers on MYC

At a glance

The findings reach people, from one lab or study; independent labs found the same change in cells. 44 independent labs in 16 countries.

“the upregulation of MYC and MHC II signaling as relatively conserved features correlating with poor prognosis”
The lifelong transcriptomic landscape of human blood cellsProtein & cell2026doi:10.1093/procel/pwag064

6 of its findings point the other way.

Cells: replicated by independent labs. Worms or flies, mice and humans: a single group.
  • 44 independent labs in 16 countries
  • 6 findings against
  • Funders: National Institutes of Health and others
  • 5 of 92 findings with company ties
  • Human trial6
  • Humans30
  • Animals141
  • Model organisms10
  • Cells93
  • In silico11

Interventions

10

Exercise

upin mice1upin reviews1

2 studies
  1. Exercise induces MYC.

    “is the most responsive to exercise in skeletal muscle and is enriched within the muscle fiber”

    Reviewskeletal muscle

    Exercise-Induced MYC as an Epigenetic Reprogramming Factor That Combats Skeletal Muscle Aging

    Exercise and sport sciences reviews

  2. Exercise increases MYC in mice.

    “Myc is the OKSM factor most induced by exercise in muscle and was elevated following exercise training in aged mice.”

    Animalsskeletal muscle

    A molecular signature defining exercise adaptation with ageing and in vivo partial reprogramming in skeletal muscle

    The Journal of physiology

More on Exercise

Simvastatin

downin human cells1

1 study
  1. Simvastatin decreases MYC in vitro.

    “SV inhibited the PKM2/STAT3/c-MYC pathway by targeting PKM2, leading to reduced c-MYC expression”

    Cellsin vitro

    Simvastatin Targets PKM2 to Alter Metabolic Reprogramming in Hepatic Stellate Cells and Mitigate Liver Fibrosis

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

More on Simvastatin

Alternative oxidase

downin mice1

1 study
  1. Alternative oxidase decreases MYC in complex III-deficient mice.

    “Transgenic alternative oxidase dampens mitochondrial integrated stress response and the c-MYC induction”

    Animalsin complex III-deficient micetransgenic

    Mitochondrial complex III deficiency drives c-MYC overexpression and illicit cell cycle entry leading to senescence and segmental progeria

    Nature communications

More on Alternative oxidase

Glucose

upin reviews1

1 study
  1. Glucose induces MYC.

    “it has been known for decades that Myc is induced by glucose in β-cells”

    Reviewpancreatic beta cell

    The many lives of Myc in the pancreatic β-cell

    The Journal of biological chemistry

More on Glucose

Decitabine

downin P. promelas cells1

1 study
  1. Decitabine decreases MYC in P. promelas cells (DNA demethylation in EPC cells).

    “DNA demethylation suppressed the transcription of myc and its downstream target, telomerase reverse transcriptase (tert)”

    CellsDNA demethylation in EPC cells

    DNA demethylation with 5-aza-2'-deoxycytidine induces the senescence-associated secretory phenotype in the immortal fish cell line, EPC

    Gene

More on Decitabine

Dietary restriction

upin flies1

1 study
  1. Dietary restriction increases MYC in flies.

    “through up-regulation of dMyc in the intestinal epithelium”

    Model organismsintestinal epithelium

    Dietary restriction improves intestinal cellular fitness to enhance gut barrier function and lifespan in D. melanogaster

    PLoS genetics

More on Dietary restriction

Everolimus

downin rats1

1 study
  1. Everolimus decreases MYC in rats (counter-regulates the age-induced increase in kidney c-Myc).

    “c-Myc, which has been shown to regulate aging, was induced by aging in the kidney and counter-regulated by RAD001”

    Animalscounter-regulates the age-induced increase in kidney c-Myckidneylow concentrationshort-term

    Short-term Low-Dose mTORC1 Inhibition in Aged Rats Counter-Regulates Age-Related Gene Changes and Blocks Age-Related Kidney Pathology

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on Everolimus

Folate deficiency

upin rats1

1 study
  1. Folate deficiency increases MYC in rats with age, via promoter hypomethylation.

    “Folate deficiency with age resulted in the up-regulation of proto-oncogenes (C-MYC and C-JUN) and cell cycle regulator gene Cyclin E as a result of promoter hypomethylation.”

    Animalswith age, via promoter hypomethylationliver

    Modulation of dietary folate with age confers selective hepatocellular epigenetic imprints through DNA methylation

    The Journal of nutritional biochemistry

More on Folate deficiency

Serial passage

upin human cells1

1 study
  1. Serial passage increases MYC in human cells (late phase (more than P20)).

    “the expression of senescence-related gene, p21, and oncogene, c-Myc, was significantly upregulated in the late phase, which had close relations with the obviously increased cell senescence”

    Cellslate phase (more than P20)

    Effects of Serial Passage on the Characteristics and Cardiac and Neural Differentiation of Human Umbilical Cord Wharton's Jelly-Derived Mesenchymal Stem Cells

    Stem cells international

More on Serial passage

Fish oil

downin mice1

1 study
  1. Fish oil decreases MYC in mice (compared with corn oil diet).

    “significantly lower c-Myc and c-Ha-Ras proteins were detected in spleens of FO-fed mice”

    Animalscompared with corn oil diet10% fish oil dietspleen10% of dietfemales

    Increased TGF-beta and decreased oncogene expression by omega-3 fatty acids in the spleen delays onset of autoimmune disease in B/W mice

    Journal of immunology (Baltimore, Md. : 1950)

More on Fish oil

Effects

53

Cellular senescence

downin cells2upin cells1upin human cells1downin human cells1

5 studies
  1. MYC protects against cellular senescence in cells (RAS-induced; ectopic expression of MYCΔCTD).

    “Ectopic expression of MYCΔCTD accelerates DNA repair, protects against RAS-induced senescence”

    CellsRAS-induced; ectopic expression of MYCΔCTDMYCΔCTD

    The function of MYC in base excision repair protects against RAS-induced senescence

    Nucleic acids research

  2. MYC decreases cellular senescence in cells (shown by Myc knockout).

    “Myc knockout induced a loss of the undifferentiated state of esophageal epithelial cells resulting in cellular senescence”

    Cellsshown by Myc knockoutesophageal epithelium

    Myc Supports Self-Renewal of Basal Cells in the Esophageal Epithelium

    Frontiers in cell and developmental biology

  3. MYC induces cellular senescence in human cells (shown by MYC overexpression in primary melanocytes).

    “Subsequently, MYC induced melanogenesis, increased cellular size and complexity and senescence.”

    Cellsshown by MYC overexpression in primary melanocytes

    Protooncogene MYC drives human melanocyte melanogenesis and senescence

    Cancer gene therapy

  4. MYC induces cellular senescence in cells (Low c-Myc expression in post-confluent cells).

    “consistent low level of c-Myc induced cellular senescence by activating AP4 in post-confluent RPE cells”

    CellsLow c-Myc expression in post-confluent cellsretinal pigment epithelial cell

    Differential cellular responses by oncogenic levels of c-Myc expression in long-term confluent retinal pigment epithelial cells

    Molecular and cellular biochemistry

  5. MYC prevents cellular senescence in human cells (constitutive MYC expression; OSM-induced senescence).

    “expression of MYC (c-MYC) from a constitutive promoter abrogated senescence”

    Cellsconstitutive MYC expression; OSM-induced senescence

    STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence

    Cell cycle (Georgetown, Tex.)

More on Cellular senescence

Lifespan

no changein flies1upin flies1downin mice1

3 studies
  1. MYC showed no clear effect on lifespan in flies (macrophage-specific overexpression).

    “while lifespan remains unaffected”

    Model organismsmacrophage-specific overexpressionmacrophage

    Fisetin-mediated MYC restoration improves age-associated decline in macrophage function

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  2. MYC shortens lifespan in mice (shown by body-wide postnatal knockout).

    “MycKO mice have extended lifespans that correlate with a 3- to 4-fold lower lifetime cancer incidence.”

    Animalsshown by body-wide postnatal knockout

    Premature aging and reduced cancer incidence associated with near-complete body-wide Myc inactivation

    Cell reports

  3. MYC extends lifespan in flies (shown by knockdown in enterocytes upon dietary restriction).

    “Reduction of dMyc in enterocytes induced cell death, which leads to increased gut permeability and reduced lifespan upon DR”

    Model organismsshown by knockdown in enterocytes upon dietary restrictionenterocytes

    Dietary restriction improves intestinal cellular fitness to enhance gut barrier function and lifespan in D. melanogaster

    PLoS genetics

TERT

upin human cells1upin humans1upin reviews1

3 studies
  1. MYC activates TERT in cancer.

    “The oncogene cMyc regulates gene expression for overexpression of TERT”

    Reviewin cancer

    Telomerase Biology Associations Offer Keys to Cancer and Aging Therapeutics

    Current aging science

  2. MYC activates TERT in cells that escaped oncogene-induced senescence.

    “acquired chromatin changes that promoted c-Myc-dependent expression of the human telomerase reverse transcriptase gene (hTERT)”

    Cellsin cells that escaped oncogene-induced senescence

    Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence

    Proceedings of the National Academy of Sciences of the United States of America

  3. MYC activates TERT in humans (proposed mechanism, hedged as possible).

    “myc overexpression may cause telomerase reactivation and telomere stabilization”

    Reviewproposed mechanism, hedged as possible

    Telomeres, telomerase, and myc. An update

    Mutation research

More on TERT

Chemotaxis

upin human cells2

2 studies
  1. MYC increases chemotaxis in human cells (shown by knockdown in MDMs from young donors).

    “In MDMs from young donors, knockdown of MYC or USF1 decreases phagocytosis and chemotaxis”

    Cellsshown by knockdown in MDMs from young donors

    Aging-related defects in macrophage function are driven by MYC and USF1 transcriptional programs

    Cell reports

  2. MYC increases chemotaxis in human cells (shown by knockdown in MDMs from young donors).

    “In MDMs from young donors, knockdown of MYC or USF1 decreased phagocytosis and chemotaxis and altered expression of genes”

    Cellsshown by knockdown in MDMs from young donors

    Ageing-related defects in macrophage function are driven by MYC and USF1 transcriptional programmes

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

Phagocytosis

upin human cells2

2 studies
  1. MYC increases phagocytosis in human cells (shown by knockdown in MDMs from young donors).

    “In MDMs from young donors, knockdown of MYC or USF1 decreases phagocytosis and chemotaxis”

    Cellsshown by knockdown in MDMs from young donors

    Aging-related defects in macrophage function are driven by MYC and USF1 transcriptional programs

    Cell reports

  2. MYC increases phagocytosis in human cells (shown by knockdown in MDMs from young donors).

    “In MDMs from young donors, knockdown of MYC or USF1 decreased phagocytosis and chemotaxis and altered expression of genes”

    Cellsshown by knockdown in MDMs from young donors

    Ageing-related defects in macrophage function are driven by MYC and USF1 transcriptional programmes

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

Apoptosis

downin flies1upin human cells1

2 studies
  1. MYC induces apoptosis in human cells (alone or together with RAS; hydroxytamoxifen-inducible MycER).

    “activation of MYC alone or together with RAS triggered DNA damage, induction of p53 and massive apoptosis”

    Cellsalone or together with RAS; hydroxytamoxifen-inducible MycER

    MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts

    Cell cycle (Georgetown, Tex.)

  2. MYC prevents apoptosis in flies (shown by knockdown in enterocytes).

    “Reduction of dMyc in enterocytes induced cell death”

    Model organismsshown by knockdown in enterocytesenterocytes

    Dietary restriction improves intestinal cellular fitness to enhance gut barrier function and lifespan in D. melanogaster

    PLoS genetics

More on Apoptosis

M2-RELATEDGENEEXPRESSION

no changein mouse cells1upin mouse cells1

1 study
  1. MYC showed no clear effect on M2-RELATEDGENEEXPRESSION in mouse cells (c-Myc suppression in macrophages from old mice).

    “c-Myc suppression did not affect M2-related genes in old-mouse macrophages”

    Cellsc-Myc suppression in macrophages from old micemacrophage

    Age-related dysfunction of p53-regulated phagocytic activity in macrophages

    Biochemical and biophysical research communications

  2. MYC increases M2-RELATEDGENEEXPRESSION in mouse cells (shown by c-Myc suppression in macrophages from young mice).

    “chemically induced p53 decreased phagocytic activity and c-Myc levels, with the latter change reducing M2-related genes”

    Cellsshown by c-Myc suppression in macrophages from young micemacrophage

    Age-related dysfunction of p53-regulated phagocytic activity in macrophages

    Biochemical and biophysical research communications

More on M2-RELATEDGENEEXPRESSION

Synaptogenesis markers

no changein cells1

1 study
  1. MYC showed no clear effect on synaptogenesis markers in cells (shown by c-Myc inhibition).

    “c-Myc inhibition reduced FOXO1 and its phosphorylated forms but did not affect synaptogenesis markers”

    Cellsshown by c-Myc inhibition

    Post-Translational Forms of c-Myc in Neural Degeneration and Repair

    International journal of molecular sciences

More on Synaptogenesis markers

PI3K–AKT signaling

upin mouse cells1

1 study
  1. MYC activates PI3K–AKT signaling in mouse cells (positive feedback loop).

    “c-Myc formed a positive feedback loop with the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway, sustaining osteoclast activity”

    Cellspositive feedback loop

    CIP2A promotes osteoclastogenesis and postmenopausal bone loss by activating a novel HMGA1–c-Myc–PI3K/AKT axis

    Research SquarePreprint

More on PI3K–AKT signaling

systemic inflammation

mediatesin mice1

1 study
  1. MYC mediates systemic inflammation in mice (chr8 gain).

    “prioritized MYC (chr8 gain) and S100A9 (chr1 gain) as key drivers of systemic inflammation and multiorgan pathology”

    Animalschr8 gain

    Blood-cell chromosome changes linked to disease and death

    medRxiv : the preprint server for health sciencesPreprint

All 53

Upstream

7

Aging tissues

downin humans1downin mice1

1 study
  1. Aging tissues are linked with lower MYC in humans.

    “Aging tissues from normal mice and humans also downregulate Myc”

    Humans

    Premature aging and reduced cancer incidence associated with near-complete body-wide Myc inactivation

    Cell reports

  2. Aging tissues decrease MYC in mice.

    “Aging tissues from normal mice and humans also downregulate Myc”

    Animals

    Premature aging and reduced cancer incidence associated with near-complete body-wide Myc inactivation

    Cell reports

HMGA1

upin mouse cells1

1 study
  1. HMGA1 increases MYC in mouse cells (HMGA1 binding to distal regulatory elements).

    “identified c-Myc as a direct transcriptional target of HMGA1, which bound distal regulatory elements to enhance c-Myc transcription”

    CellsHMGA1 binding to distal regulatory elements

    CIP2A promotes osteoclastogenesis and postmenopausal bone loss by activating a novel HMGA1–c-Myc–PI3K/AKT axis

    Research SquarePreprint

More on HMGA1

TNF-alpha

upin human cells1

1 study
  1. TNF-alpha increases MYC in amnion epithelial cells (p < 0.01).

    “KLF4 downregulation (p < 0.05) and an increase in c-MYC (p < 0.01) in mRNA and protein levels were observed.”

    Cellsin amnion epithelial cellsamnion epithelial cells50 ng/mL48 h

    The Impacts of TNF-α-Induced Inflammation on Amnion Epithelial Cells: Exploring Stem Cell Gene Expression, Senescence, Inflammatory Responses, and Cellular Transition

    American journal of reproductive immunology (New York, N.Y. : 1989)

More on TNF-alpha

HOPX

downin human cells1

1 study
  1. HOPX decreases MYC in human cells.

    “HOPX binds to promoters and exerts repressive effects on the expression of MYC and NR4A1”

    Cells

    Homeodomain-only protein suppresses proliferation and contributes to differentiation- and age-related reduced CD8⁺ T cell expansion

    Frontiers in immunology

More on HOPX

Respiratory complex III deficiency

upin mice1

1 study
  1. Respiratory complex III deficiency increases MYC in mice (presymptomatic).

    “triggers presymptomatic cancer-like c-MYC upregulation”

    Animalspresymptomatic

    Mitochondrial complex III deficiency drives c-MYC overexpression and illicit cell cycle entry leading to senescence and segmental progeria

    Nature communications

More on Respiratory complex III deficiency

Diabetes mellitus

upin mice1

1 study
  1. Diabetes mellitus increases MYC in mice (diabetic mice).

    “In diabetic mice, the levels of p-PKCα, p-p38, c-myc, and c-jun were all increased in the colon tissues.”

    Animalsdiabetic micecolon

    Resveratrol attenuates diabetes-associated cell centrosome amplification via inhibiting the PKCα-p38 to c-myc/c-jun pathway

    Acta biochimica et biophysica Sinica

More on Diabetes mellitus

ARID3A

upin mice1

1 study
  1. ARID3A increases MYC in mice (at the pre-B and immature B cell stages).

    “The increased Arid3a leads higher Myc and Bhlhe41, and lower Siglec-G and CD72 at the pre-B and immature B cell stages”

    Animalsat the pre-B and immature B cell stages

    Crucial Role of Increased Arid3a at the Pre-B and Immature B Cell Stages for B1a Cell Generation

    Frontiers in immunology

More on ARID3A

Associations

15

Poor prognosis

upin humans1

1 study
  1. MYC is associated with poor prognosis in humans across hematological malignancies.

    “the upregulation of MYC and MHC II signaling as relatively conserved features correlating with poor prognosis”

    Humansacross hematological malignanciesn = 116

    The lifelong transcriptomic landscape of human blood cells

    Protein & cell

Diabetic retinopathy

upin humans1

1 study
  1. MYC is associated with diabetic retinopathy in humans (DR animal model versus control).

    “the expression levels of MYC and LOX in the retina were significantly higher in DR group than in the control group (P < 0.05)”

    AnimalsDR animal model versus controlretina

    Multi-omics and experimental validation studies reveal key biomarkers of cellular senescence in diabetic retinopathy

    Diabetology & metabolic syndrome

More on Diabetic retinopathy

Late-life training proteome

mixedin silico1

1 study
  1. MYC is associated with late-life training proteome in silico.

    “Computational cistrome analysis identified MYC as a regulator of the late-life training proteome, in agreement with prior transcriptional analyses.”

    In silicoregulator inferred by computational cistrome analysis after progressive weighted wheel runningskeletal musclefemales

    Methylome-proteome integration after late-life voluntary exercise training reveals regulation and target information for improved skeletal muscle health

    The Journal of physiology

More on Late-life training proteome

Frailty

mixedin humans1

1 study
  1. MYC is associated with frailty in humans (non-frail versus frail participants).

    “TF involved in age-related pathways (e.g., FOXO3 and MYC) shows different expression patterns between non-frail and frail participants.”

    Humansnon-frail versus frail participantswhole blood

    OVCH1 Antisense RNA 1 is differentially expressed between non-frail and frail old adults

    GeroScience

Oral premalignant lesions

upin humans1

1 study
  1. MYC is associated with oral premalignant lesions in humans (later stages).

    “Later stages of oral premalignant lesions exhibit elevated MYC levels and cellular dysplasia.”

    Humanslater stagesoral premalignant lesion

    Irreversible cell cycle exit associated with senescence is mediated by constitutive MYC degradation

    Cell reports

More on Oral premalignant lesions

Early oral carcinogenesis

downin humans1

1 study
  1. MYC is associated with early oral carcinogenesis in humans.

    “In early oral carcinogenesis, epithelial cells exhibit MYC loss and become senescent as a safeguard against malignant transformation.”

    Humansepithelial cells

    Irreversible cell cycle exit associated with senescence is mediated by constitutive MYC degradation

    Cell reports

More on Early oral carcinogenesis

Cancer

upin mice1

1 study
  1. MYC raises the risk of cancer in mice (shown by body-wide postnatal knockout) (3- to 4-fold lower lifetime cancer incidence in MycKO mice).

    “MycKO mice have extended lifespans that correlate with a 3- to 4-fold lower lifetime cancer incidence.”

    Animalsshown by body-wide postnatal knockout

    Premature aging and reduced cancer incidence associated with near-complete body-wide Myc inactivation

    Cell reports

More on Cancer

Normal aging

downin mice1

1 study
  1. MYC is associated with normal aging in mice (Myc expression in aging tissues).

    “Aging tissues from normal mice and humans also down-regulate Myc and gradually deregulate many of the same Myc target gene sets”

    AnimalsMyc expression in aging tissues

    Premature Aging and Reduced Cancer Incidence Associated with Near-Complete Body-Wide Myc Inactivation

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

Pigmentation

upin humans1

1 study
  1. MYC is associated with pigmentation in human nevi regions with high pigmentation.

    “we also found strong expression of MYC in regions of human nevi displaying high pigmentation and high expression of senescence marker p16.”

    Humansin human nevi regions with high pigmentationnevus

    Protooncogene MYC drives human melanocyte melanogenesis and senescence

    Cancer gene therapy

HSC aging candidate genes

mixedin silico1

1 study
  1. MYC is associated with HSC aging candidate genes in silico (predicted from the microRNA-transcription factor-gene regulatory network).

    “TFs MYC and SP1 were identified to regulate various candidate genes”

    In silicopredicted from the microRNA-transcription factor-gene regulatory network

    An integrated network analysis approach to identify potential key genes, transcription factors, and microRNAs regulating human hematopoietic stem cell aging

    Molecular omics

All 15

Funding

3 grants since 2024

National Cancer Institute$6.6MBiotechnology and Biological Sciences Research CouncilNatural Science Foundation of Hunan Province

Contains public sector information licensed under the Open Government Licence v3.0.

Latest

Dec 2025: 6Jan 2026: 9Feb 2026: 10Mar 2026: 6Apr 2026: 3May 2026: 7Jun 2026: 4Jul 2026: 6Aug 2026: 6Sep 2026: 3Oct 2026: 8Nov 2026: 674 papers in 12 months
bioRxiv

Human cell types recovered differently after partial reprogramming

Experiments in human cells found that lower DNA-based age estimates did not necessarily accompany recovery of specialized identity and function.Experiments in human cells found that lower DNA-based age estimates did not necessarily accompany recovery of specialized identity and function.

Preprint: human cell studyPartial reprogramming
Journal of Cellular Physiology

Blueberry extract eased signs of testicular aging in mice

An experiment in middle-aged mice found that a blueberry extract restored sperm movement and reversed degeneration of the tubes where sperm develop.An experiment in middle-aged mice found that a blueberry extract restored sperm movement and reversed degeneration of the tubes where sperm develop.

Mouse studyInterventions
Aging Cell

Partial cell reprogramming reduced stroke damage in aged mice

An experiment in aged mice found smaller damaged brain areas and better movement-related test results 48 hours after stroke.An experiment in aged mice found smaller damaged brain areas and better movement-related test results 48 hours after stroke.

Mouse study · 14 micePartial reprogramming
Journal of Translational Medicine

Packages from immature bone-forming cells reduced bone loss in mice

In a mouse experiment, injections of packages released by immature bone-forming cells improved bone structure after ovary removal.In a mouse experiment, injections of packages released by immature bone-forming cells improved bone structure after ovary removal.

Mouse studyBones and joints

See all 332 papers on MYC